Capital International Sarl Boosts Stock Holdings in Danaher Co. (NYSE:DHR)
Capital International Sarl boosted its position in shares of Danaher Co. (NYSE:DHR) by 5.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,189 shares of the conglomerate’s stock after buying an additional 2,679 shares during the period. Danaher accounts for about 1.2% of Capital International Sarl’s portfolio, making the stock its 26th largest holding. Capital International Sarl’s holdings in Danaher were worth $7,856,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the business. KCM Investment Advisors LLC boosted its holdings in shares of Danaher by 1.4% during the 4th quarter. KCM Investment Advisors LLC now owns 59,333 shares of the conglomerate’s stock worth $9,106,000 after purchasing an additional 814 shares during the last quarter. Equitable Holdings Inc. acquired a new stake in Danaher during the fourth quarter valued at approximately $324,000. Bamco Inc. NY lifted its stake in Danaher by 8.1% during the fourth quarter. Bamco Inc. NY now owns 2,194 shares of the conglomerate’s stock valued at $337,000 after purchasing an additional 165 shares during the last quarter. Brinker Capital Inc. raised its holdings in shares of Danaher by 5.4% during the fourth quarter. Brinker Capital Inc. now owns 85,748 shares of the conglomerate’s stock valued at $13,162,000 after acquiring an additional 4,361 shares during the period. Finally, Profund Advisors LLC raised its holdings in shares of Danaher by 10.2% during the fourth quarter. Profund Advisors LLC now owns 18,022 shares of the conglomerate’s stock valued at $2,766,000 after acquiring an additional 1,666 shares during the period. Institutional investors own 79.72% of the company’s stock.
Danaher stock traded up $8.32 during midday trading on Thursday, hitting $137.64. 1,794,955 shares of the stock were exchanged, compared to its average volume of 5,000,333. The company has a fifty day simple moving average of $149.39 and a two-hundred day simple moving average of $147.49. Danaher Co. has a 52 week low of $119.60 and a 52 week high of $169.19. The stock has a market capitalization of $89.92 billion, a PE ratio of 33.99, a P/E/G ratio of 2.14 and a beta of 0.96. The company has a quick ratio of 4.86, a current ratio of 5.19 and a debt-to-equity ratio of 0.75.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a dividend of $0.18 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Thursday, March 26th. This represents a $0.72 annualized dividend and a yield of 0.52%. Danaher’s dividend payout ratio (DPR) is presently 15.38%.
In related news, SVP Angela S. Lalor sold 18,267 shares of the business’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $161.49, for a total transaction of $2,949,937.83. Following the transaction, the senior vice president now directly owns 56,782 shares in the company, valued at $9,169,725.18. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Thomas Patrick Joyce, Jr. sold 132,474 shares of the business’s stock in a transaction on Friday, January 31st. The stock was sold at an average price of $162.51, for a total transaction of $21,528,349.74. Following the transaction, the chief executive officer now owns 246,027 shares in the company, valued at $39,981,847.77. The disclosure for this sale can be found here. Insiders have sold a total of 297,385 shares of company stock worth $48,153,397 in the last three months. 11.40% of the stock is owned by insiders.
A number of equities research analysts have recently issued reports on DHR shares. Royal Bank of Canada upgraded shares of Danaher from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $151.00 to $157.00 in a report on Wednesday. JPMorgan Chase & Co. raised their target price on shares of Danaher from $155.00 to $175.00 in a research note on Thursday, December 19th. Bank of America raised their target price on shares of Danaher from $165.00 to $188.00 and gave the company a “buy” rating in a research note on Friday, January 31st. Citigroup reduced their target price on shares of Danaher from $195.00 to $160.00 and set a “buy” rating on the stock in a research note on Friday, March 20th. Finally, UBS Group raised their target price on shares of Danaher from $165.00 to $176.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and eleven have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $166.41.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: Consumer behavior in bull markets
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.